Skip to main content
SpringerLink
Log in
Book cover

Adrenal Glands pp 75–85Cite as

Ectopic Cushing’s Syndrome

  • Chapter

  • 1276 Accesses

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ajani JA, Legha SS, Karlin DA, Stratton Hill C (1983) Combination chemotherapy of metastatic carcinoid tumors with 5-FU, adriamycin, mitomycin and methyl-CCNU. Proc Am Assoc Clin Oncol 2:124 (Abstract C-486)

    Google Scholar 

  2. Amikura K, Alexander HR, Norton JA, Doppman JL, Jensen RT, Nieman L, Cutler G, Chrousos G, Fraker DL (1995) Role of surgery in management of adrenocorticotropic hormone-producing islet cell tumors of the pancreas. Surgery 118:1125–1130

    PubMed  Google Scholar 

  3. Aniszewski JP, Young WF Jr, Thompson GB, Grant CS, van Heerden JA (2001) Cushing syndrome due to ectopic adrenocorticotropic hormone secretion. World J Surg 25:934–940

    Article  PubMed  Google Scholar 

  4. Arioglu E, Doppman J, Gomes M, Kleiner D, Mauro D, Barlow C, Papanicolaou DA (1998) Cushing’s syndrome caused by corticotropin secretion by pulmonary tumor-lets. N Engl J Med 24;339:883–886

    Article  Google Scholar 

  5. Arnaldi G, de Keyzer Y, Gasc JM, Clauser E, Bertagna X (1998) Vasopressin receptors modulate the pharmacological phenotypes of Cushing’s syndrome. Endocr Res 24: 807–816

    PubMed  Google Scholar 

  6. Aron DC, Raff H, Findling JW (1997) Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing’s syndrome. J Clin Endocrinol Metab 82:1780–1785

    Article  PubMed  Google Scholar 

  7. Bertagna X (1994) Proopiomelanocortin-derived peptides. Endocrinol Metab Clin North Am 23:467–485

    PubMed  Google Scholar 

  8. Beuschlein F, Hammer GD (2002) Ectopic proopiomelanocortin syndrome. Endocrinol Metab Clin North Am 31:191–234

    Article  PubMed  Google Scholar 

  9. Blumgart LH, Allison DJ (1982) Resection and embolization in the management of secondary hepatic tumors. World J Surg 6:32–45

    Article  PubMed  Google Scholar 

  10. Bukowski RM, John KG, Peterson RF, Stephens RL, Rivkin SE, Neilan B, Costanzi JH (1987) A phase II trial of combination chemotherapy in patients with metastatic carcinoid tumors. A Southwest Oncology Group Study. Cancer 60:2891–2895

    PubMed  Google Scholar 

  11. Christin-Maitre S, Chabbert-Buffet N, Mure A, Boukhris R, Bouchard P (1996) Use of somatostatin analog for localization and treatment of ACTH secreting bronchial carcinoid tumor. Chest 109:845–846

    PubMed  Google Scholar 

  12. Clark ES, Carney JA (1984) Pancreatic islet cell tumor associated with Cushing’s syndrome. Am J Surg Pathol 8:917–924

    PubMed  Google Scholar 

  13. Comi RJ, Gorden P (1998) Long-term medical treatment of ectopic ACTH syndrome. South Med J 91:1014–1018

    PubMed  Google Scholar 

  14. De Keyzer Y, Bertagna X, Lenne F, Girard F, Luton JP, Kahn A (1985) Altered proopiomelanocortin gene expression in adrenocorticotropin-producing nonpituitary tumors. Comparative studies with corticotropic adenomas and normal pituitaries. J Clin Invest 76:1892–1898

    PubMed  Google Scholar 

  15. De Keyzer Y, Bertagna X, Luton JP, Kahn A (1989) Variable modes of proopiomelanocortin gene transcription in human tumors. Mol Endocrinol 3:215–223

    PubMed  Google Scholar 

  16. De Keyzer Y, Lenne F, Auzan C, Jegou S, Rene P, Vaudry H, Kuhn JM, Luton JP, Clauser E, Bertagna X (1996) The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome. J Clin Invest 97:1311–1318

    PubMed  Google Scholar 

  17. De Keyzer Y, Raffin-Sanson ML, Picon A, Bertagna X (2001) Syndromes of ectopic ACTH secretion: recent pathophysiological aspects. In: Margioris AN, Chrousos GP (eds) Adrenal disorders. Humana Press, Totowa, NJ, pp 165–178

    Google Scholar 

  18. DeBold CR, Menefee JK, Nicholson WE, Orth DN (1988) Proopiomelanocortin gene is expressed in many normal human tissues and in tumors not associated with ectopic adrenocorticotropin syndrome. Mol Endocrinol 2:862–870

    PubMed  Google Scholar 

  19. Delisle L, Boyer MJ, Warr D, Killinger D, Payne D, Yeoh JL, Feld R (1993) Ectopic corticotropin syndrome and small-cell carcinoma of the lung. Clinical features, outcome, and complications. Ann Intern Med 153:746–752

    Article  Google Scholar 

  20. Dichek HL, Nieman LK, Oldfield EH, Pass HI, Malley JD, Cutler GB Jr (1994) A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing’s syndrome. J Clin Endocrinol Metab 78:418–422

    Article  PubMed  Google Scholar 

  21. Doppman JL, Chang R, Oldfield EH, Chrousos G, Stratakis CA, Nieman LK (1999) The hypoplastic inferior petrosal sinus: a potential source of false-negative results in petrosal sampling for Cushing’s disease. J Clin Endocrinol Metab 84:533–540

    Article  PubMed  Google Scholar 

  22. Doppman JL, Nieman LK, Cutler GB Jr, Chrousos GP, Fraker DL, Norton JA, Jensen RT (1994) Adrenocorticotropic hormone-secreting islet cell tumors: are they always malignant? Radiology 190:59–64

    PubMed  Google Scholar 

  23. Doppman JL, Pass HI, Nieman LK, Findling JW, Dwyer AJ, Feuerstein IM, Ling A, Travis WD, Cutler GB Jr, Chrousos GP, Loriaux DL (1991) Detection of ACTH-producing bronchial carcinoid tumors: MR imaging vs CT. AJR 156:39–43

    PubMed  Google Scholar 

  24. Doppman JL (1994) Somatostatin receptor scintigraphy and the ectopic ACTH syndrome. The solution or just another test? Am J Med 96:303–304

    Article  PubMed  Google Scholar 

  25. Du Pont AG, Somers G, Van Steiterghem AC, Warson F, Vanhaelst L (1984) Ectopic adrenocorticotropin production: disappearance after removal of inflammatory tissue. J Clin Endocrinol Metab 58:654–658

    PubMed  Google Scholar 

  26. Eriksson B, Oberg K, Alm G, Karlsson A, Lundqvist G, Andersson T, Wilander E, Wide L (1986) Treatment of malignant endocrine pancreatic tumors with human leucocyte interferon. Lancet 2:1307–1309

    Article  PubMed  Google Scholar 

  27. Farwell AP, Devlin JT, Stewart JA (1988) Total suppression of cortisol excretion by ketoconazole in the therapy of the ectopic adrenocorticotropic hormone syndrome. Am J Med 84:1063–1066

    Article  PubMed  Google Scholar 

  28. Findling JW, Kehoe ME, Shaker JL, Raff H (1991) Routine inferior petrosal sinus sampling in the differential diagnosis of adrenocortical (ACTH)-dependent Cushing’s syndrome: early recognition of the occult ectopic ACTH syndrome. J Clin Endocrinol Metab 73:408–413

    PubMed  Google Scholar 

  29. Friedman TC, Loh YP, Birch NP (1994) In vitro processing of proopiomelanocortin by recombinant PC1 (SPC3). Endocrinology 135:854–862

    Article  PubMed  Google Scholar 

  30. Grossman AB, Howlett TA, Perry L, Coy DH, Savage MO, Lavender-P, Rees LH, Besser GM (1988) CRF in the differential diagnosis of Cushing’s syndrome: a comparison with the dexamethasone suppression test. Clin Endocrinol (Oxf) 29:167–178

    Google Scholar 

  31. Harbour JW, Lai SL, Whang-Peng J, Gazdar AF, Minna JD, Kaye FJ (1988) Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 241:353–357

    PubMed  Google Scholar 

  32. Howlett TA, Drury PL, Perry L, Doniach I, Rees LH, Besser GM (1986) Diagnosis and management of ACTH-dependent Cushing’s syndrome: comparison of the features in ectopic and pituitary ACTH production. Clin Endocrinol (Oxf) 24:699–713

    Google Scholar 

  33. Invitti C, Giraldi FP, Cavagnini F (1999) Inferior petrosal sinus sampling in patients with Cushing’s syndrome and contradictory responses to dynamic testing. Clin Endocrinol (Oxf) 51:255–257

    Article  Google Scholar 

  34. Invitti C, Giraldi FP, de Martin M, Cavagnini F (1999) Diagnosis and management of Cushing’s syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis. J Clin Endocrinol Metab 84:440–448

    Article  PubMed  Google Scholar 

  35. Ishido H, Yamashita N, Kitaoka M, Tanaka Y, Ogata E (1994) A case of ectopic ACTH syndrome associated with Zollinger-Ellison syndrome: long-term survival with chemical adrenalectomy. Endocr J 41:171–176

    PubMed  Google Scholar 

  36. Jeannotte L, Burbach JP, Drouin J (1987) Unusual proopiomelanocortin ribonucleic acids in extrapituitary tissues: intronless transcripts in testes and log poly(A) tails in hypothalamus. Mol Endocr 1:749–757

    Google Scholar 

  37. Kaltsas T, Krassas GE, Pontikides N, Tsotsia E, Tsagarakis S (2003) Cyclical Cushing syndrome caused by intermittent ectopic ACTH hormonogenesis responsive to somatostatin analogues. Endocrinologist 13:7–11

    Google Scholar 

  38. Kato Y, Ferguson TB, Bennett DE, Burford TH (1969) Oat cell carcinoma of the lung. A review of 138 cases. Cancer 23:517–524

    PubMed  Google Scholar 

  39. Kaye TB, Crapo L (1990) The Cushing syndrome: An update on diagnostic tests. Ann Intern Med 112:434–444

    PubMed  Google Scholar 

  40. Kuhn JM, Proeschel MF, Seurin DJ, Bertagna XY, Luton JP, Girard FL (1989) Comparative assessment of ACTH and lipotropin plasma levels in the diagnosis and follow-up of patients with Cushing’s syndrome: a study of 210 cases. Am J Med 86:678–684

    Article  PubMed  Google Scholar 

  41. Kulke MH, Mayer RJ (1999) Carcinoid tumors. N Engl J Med 340:858–868

    Article  PubMed  Google Scholar 

  42. Lam EW, La Thangue NB (1994) DP and E2F proteins: coordinating transcription with cell cycle progression. Curr Opin Cell Biol 6:859–866. Review

    Article  PubMed  Google Scholar 

  43. Lamberts SWS, Krenning EP, Reubi JC (1991) The role of somatostatin and its analogue in the diagnosis and treatment of tumors. Endocr Rev 12:450–482

    PubMed  Google Scholar 

  44. Liddle GW, Island DP, Meador CK (1962) Normal and abnormal regulation of corticotropin secretion in man. Recent Prog Horm Res 18:125–166

    Google Scholar 

  45. Lyons DF, Eisen BR, Clark MR, Pysher TJ, Welsh JD, Kem DC (1984) Concurrent Cushing’s and Zollinger-Ellison syndromes in a patient with islet cell carcinoma. Case report and review of the literature. Am J Med 76: 729–733

    Article  PubMed  Google Scholar 

  46. Makita M, Maeda Y, Hashimoto K, Nakase K, Takenaka K, Shinagawa K, Ishimaru F, Ikeda K, Niiya K, Ogura T, Harada M (2003) Acute lymphoblastic leukemia with large molecular ACTH production. Ann Hematol 82: 448–451

    Article  PubMed  Google Scholar 

  47. Malerbi DA, Mendonca BB, Liberman B, Toledo SP, Corradini MC, Cunha-Neto MB, Fragoso MC, Wajchenberg BL (1993) The desmopressin stimulation test in the differential diagnosis of Cushing’s syndrome. Clin Endocrinol (Oxf) 38:463–472

    Google Scholar 

  48. Miller JW, Crapo L (1993) The medical treatment of Cushing’s syndrome. Endocr Rev 14:443–458

    Google Scholar 

  49. Moertel CG, Kvols LK, O’Connell MJ, Rubin J (1991) Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin: evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Cancer 68:227–232

    PubMed  Google Scholar 

  50. Naidich DP (1990) CT/MR correlation in the evaluation of tracheobronchial neoplasia. Radiol Clin North Am 28: 555–571

    PubMed  Google Scholar 

  51. Newell-Price J, Perry L, Medbak S, Monson J, Savage M, Besser M, Grossman A (1997) A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 82:176–181

    Article  PubMed  Google Scholar 

  52. Newell-Price J, Trainer P, Besser M, Grossman A (1998) The diagnosis and differential diagnosis of Cushing’s syndrome and pseudo-Cushing’s states. Endocr Rev 19: 647–672

    Article  PubMed  Google Scholar 

  53. Nieman LK, Chrousos GP, Oldfield EH, Avgerinos PC, Cutler GB Jr, Loriaux DL (1986) The ovine corticotropin-releasing hormone stimulation test and the dexamethasone suppression test in the differential diagnosis of Cushing’s syndrome. Ann Intern Med 105:862–867

    PubMed  Google Scholar 

  54. Oberg K, Norheim I, Alm G (1989) Treatment of malignant carcinoid tumors: a randomized controlled study of streptozotocin plus 5-FU and human leucocyte interferon. Eur J Cancer Clin Oncol 25:1475–1479

    Article  PubMed  Google Scholar 

  55. Odell WD (1991) Ectopic ACTH secretion: a misnomer. Endocrinol Metab Clin North Am 20:371–379

    PubMed  Google Scholar 

  56. Oldfield EH, Doppman JL, Nieman LK, Chrousos GP, Miller DL, Ktaz DA, Cutler GB Jr, Loriaux DL (1991) Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing’s syndrome. N Engl J Med 325:896–905

    Google Scholar 

  57. Orth DN (1995) Cushing’s syndrome. N Engl J Med 332:791–803

    Article  PubMed  Google Scholar 

  58. Phlipponneau M, Nocaudie M, Epelbaum J, De Keyzer Y, Lalau JD, Marchandise X, Bertagna X (1994) Somatostatin analogs for the localization and preoperative treatment of an adrenocorticotropin-secreting bronchial carcinoid tumor. J Clin Endocrinol Metab 78:20–24

    Article  PubMed  Google Scholar 

  59. Picon A, Bertagna X, de Keyzer Y (1999) Analysis of the human proopiomelanocortin gene promoter in a small cell lung carcinoma cell line reveals an unusual role for E2F transcription factors. Oncogene 18:2627–2633

    Article  PubMed  Google Scholar 

  60. Raffin-Sanson ML, Massias JF, Dumont C, Raux-Demay MC, Proeschel MF, Luton JP, Bertagna X (1996) High plasma proopiomelanocortin in aggressive adrenocorticotropin-secreting tumors. J Clin Endocrinol Metab 81: 4272–4277

    Article  PubMed  Google Scholar 

  61. Raffin-Sanson ML, de Keyzer Y, Bertagna X (2003) Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions. Eur J Endocrinol 149:79–90

    Article  PubMed  Google Scholar 

  62. Rena O, Filosso PL, Maggi G, Casadio C (2003) Neuroendocrine tumors (carcinoid) of the thymic gland. Ann Thorac Surg 75:633

    Article  Google Scholar 

  63. Seidah NG, Marcinkiewicz M, Benjannet S, Gaspar L, Beaubien G, Mattei MG et al. (1991) Cloning and primary sequence of a mouse candidate prohormone convertase PC1 homologous to PC2, furin, and Kex2: distinct chromosomal localization and messenger RNA distribution in brain and pituitary compared to PC2. Mol Endocrinol 5:111–122

    PubMed  Google Scholar 

  64. Shepherd FA, Laskey J, Evans WK, et al. (1992) Cushing’s syndrome associated with ectopic corticotropin production and small-cell lung cancer. J Clin Oncol 10:21–27

    PubMed  Google Scholar 

  65. Shrager JB, Wright CD, Wain JC, Torchiana DF, Grillo HC, Mathisen DJ (1997) Bronchopulmonary carcinoid tumors associated with Cushing’s syndrome: a more aggressive type of typical carcinoids. J Thorac Cardiovasc Surg 114:367–375

    PubMed  Google Scholar 

  66. Smeekens SP, Steiner DF (1990) Identification of a human insulinoma cDNA encoding a novel mammalian protein structurally related to the yeast dibasic processing protease Kex 2. J Biol Chem 265:2997–3000

    PubMed  Google Scholar 

  67. Tabarin A, Valli N, Chanson P, Bachelot Y, Rohmer V, Bex-Bachellerie B, Catargi B, Roger P, Laurent F (1999) Usefulness of somatostatin receptor scintigraphy in patients with occult ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab 84:1193–1202

    Article  PubMed  Google Scholar 

  68. Takahashi H, Hakamata Y, Watanabe Y, Kikuno R, Miyata T, Numa S (1983) Complete nucleotide sequence of the human corticotropin-beta-lipotropin precursor gene. Nucleic Acids Res 11:6847–6858

    PubMed  Google Scholar 

  69. Terzolo M, Reimondo G, Ali A, Borretta G, Cesario F, Pia A, Paccotti P, Angeli A (2001) The limited value of the desmopressin test in the diagnostic approach to Cushing’s syndrome. Clin Endocrinol (Oxf) 54:609–616

    Article  Google Scholar 

  70. Terzolo M, Reimondo G, Ali A, Bovio S, Daffara F, Paccotti P, Angeli A (2001) Ectopic ACTH syndrome: molecular bases and clinical heterogeneity. Ann Oncol 12Suppl 2:S83–87

    Article  PubMed  Google Scholar 

  71. Texier PL, De Keyzer Y, Lacave R, Vieau D, Lenne F, Rojas-Miranda A, Verley JM, Luton JP, Kahn A, Bertagna X (1991) Proopiomelanocortin gene expression in normal and tumoral human lung. J Clin Endocrinol Metab 73:414–420

    PubMed  Google Scholar 

  72. Torpy DJ, Chen CC, Mullen N, Doppman JL, Carrasquillo JA, Chrousos GP, Nieman LK (1999) Lack of utility of 111In-Pentetreotide scintigraphy in localizing ectopic ACTH producing tumors: follow-up of 18 patients. J Clin Endocrinol Metab 84:1186–1192

    Article  PubMed  Google Scholar 

  73. Trainer PJ, Grossman A (1991) The diagnosis and differential diagnosis of Cushing’s syndrome. Clin Endocrinol (Oxf) 34:317–330

    Google Scholar 

  74. Tsagarakis S, Christoforaki M, Giannopoulou H, Rondogianni F, Housianakou I, Malagari C, Rontogianni D, Bellenis I, Thalassinos N (2003) A reappraisal of the utility of somatostatin receptor scintigraphy in patients with ectopic adrenocorticotropin Cushing’s syndrome. J Clin Endocrinol Metab 88:4754–4758

    Article  PubMed  Google Scholar 

  75. Tsagarakis S, Giannakenas C, Vassilakos PJ, Platis O, Belenis I, Kaskarelis J, Rontoyianni D, Thalassinos N (1995) Successful localization of an occult ACTH-secreting bronchial carcinoid tumour with 111 indium-DTPA labelled octreotide. Clin Endocrinol (Oxf). 43:763–767

    Google Scholar 

  76. Tsagarakis S, Kaskarelis IS, Kokkoris P, Malagari C, Thalassinos N (2000) The application of combined stimulation with CRH and desmopressin during bilateral petrosal sinus sampling in patients with Cushing’s syndrome. Clin Endocrinol (Oxf) 52:355–361

    Article  Google Scholar 

  77. Tsagarakis S, Thalassinos N (2001) The desmopressin test: a new tool in the functional evaluation of the pituitary-adrenal axis in patients with Cushing’s syndrome? In: Margioris AN, Chrousos GP (eds) Adrenal disorders. Humana Press, Totowa, NJ, pp 193–202

    Google Scholar 

  78. Tsagarakis S, Tsigos C, Vasiliou V, Tsiotra P, Kaskarelis J, Sotiropoulou C, Raptis SA, Thalassinos N (2002) The desmopressin and combined CRH-desmopressin tests in the differential diagnosis of ACTH-dependent Cushing’s syndrome: constraints imposed by the expression of V2 vasopressin receptors in tumors with ectopic ACTH secretion. J Clin Endocrinol Metab 87:1646–1653

    Article  PubMed  Google Scholar 

  79. Vaidya B, Richardson D, Hilton CJ, Kendall-Taylor P (1997) Adrenocorticotropin-secreting carcinoid tumour identified and treated 12 years after presentation with Cushing’s syndrome. Postgrad Med J 73:737–739

    PubMed  Google Scholar 

  80. Van Coevorden A, Laurent E, Rickaert F, van Reeth O, Van Cauter E, Mockel J (1990) Cushing’s syndrome with intermittent ectopic ACTH production. J Endocrinol Invest 13:317–326

    PubMed  Google Scholar 

  81. Van den Bruel A, Bex M, Van Dorpe J, Heyns W, Bouillon R (1998) Occult ectopic ACTH secretion due to recurrent lung carcinoid: long-term control of hypercortisolism by continuous subcutaneous infusion of octreotide. Clin Endocrinol (Oxf) 49:541–546

    Article  Google Scholar 

  82. Vella A, Thompson GB, Grant CS, van Heerden JA, Farley DR, Young WF Jr (2001) Laparoscopic adrenalectomy for adrenocorticotropin-dependent Cushing’s syndrome. J Clin Endocrinol Metab 86:1596–1599

    Article  PubMed  Google Scholar 

  83. Vieau D, Seidah NG, Mbikay M, Chretien M, Bertagna X (1994) Expression of the prohormone convertase PC2 correlates with the presence of corticotropin-like intermediate lobe peptide in human adrenocorticotropin-secreting tumors. J Clin Endocrinol Metab 79:1503–1506

    Article  PubMed  Google Scholar 

  84. Vignati F, Loli P (1996) Additive effect of ketoconazole and octreotide in the treatment of severe adrenocorticotropin-dependent hypercortisolism. J Clin Endocrinol Metab 81:2885–2890

    Article  PubMed  Google Scholar 

  85. Vincent JM, Trainer PJ, Reznek RH, Marcus AJ, Dacie JE, Armstrong P, Besser GM (1993) The radiological investigation of occult ectopic ACTH-dependent Cushing’s syndrome. Clin Radiol 48:11–17

    PubMed  Google Scholar 

  86. Wajchenberg BL, Mendonca BB, Liberman B, Pereira MA, Carneiro PC, Wakamatsu A, Kirschner MA (1994) Ectopic adrenocorticotropic hormone syndrome. Endocr Rev 15:752–787

    Google Scholar 

  87. Weiss M, Yellin A, Husza’r M, Eisenstein Z, Bar-Ziv J, Krausz Y (1994) Localization of adrenocorticotropic hormone-secreting bronchial carcinoid tumor by somatostatin-receptor scintigraphy. Ann Intern Med 121: 198–199

    PubMed  Google Scholar 

  88. White A, Clark AJL (1993) The cellular and molecular basis of the ectopic ACTH syndrome. Clin Endocrinol (Oxf) 39:131–141

    Google Scholar 

  89. White A, Gibson S (1998) ACTH precursors: biological significance and clinical relevance. Clin Endocrinol (Oxf) 48:251–255

    Article  Google Scholar 

  90. Winocour PH, Tong P, White J, Edwards A, White A, Gibson GJ, Clark F (1993) Unusual presentation and course of Cushing’s syndrome due to ectopic ACTH secretion by a bronchial carcinoma. Respir Med 87:149–151

    Article  PubMed  Google Scholar 

  91. Zeiger MA, Pass HI, Doppman JD, Nieman LK, Chrousos GP, Cutler GB Jr, Jensen RT, Norton JA (1992) Surgical strategy in the management of non-small cell ectopic adrenocorticotropic hormone syndrome. Surgery 112: 994–1000

    PubMed  Google Scholar 

  92. Zhou A, Bloomquist BT, Mains RE (1993) The prohormone convertases PC1 and PC2 mediate distinct endoproteolytic cleavages in a strict temporal order during proopiomelanocortin biosynthetic processing. J Biol Chem 268:1763–1769

    PubMed  Google Scholar 

  93. Zhu L, Domenico DR, Howard JM (1996) Metastatic pancreatic neuroendocrine carcinoma causing Cushing’s syndrome. ACTH secretion by metastases 3 years after resection of nonfunctioning primary cancer. Int J Pancreatol 19:205–208

    PubMed  Google Scholar 

Download references

Authors
  1. D. Vassiliadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Tsagarakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. Thalassinos
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Director 1st Surgical Clinic, Hygeia Hospital, 227 Kifissias Avenue, 14561, Kifissia, Greece

    Dimitrios Linos

  2. Department of Surgery, Mayo Clinic, First Street SW 200, Rochester, MN, 55905, USA

    Jon A. van Heerden

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Vassiliadi, D., Tsagarakis, S., Thalassinos, N. (2005). Ectopic Cushing’s Syndrome. In: Linos, D., van Heerden, J.A. (eds) Adrenal Glands. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26861-8_8

Download citation

  • DOI: https://doi.org/10.1007/3-540-26861-8_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-41099-7

  • Online ISBN: 978-3-540-26861-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation